Efficacy and safety of veliparib plus chemotherapy for the treatment of lung cancer: A systematic review of clinical trials.

Amin Daei SorkhabiAsra FazlollahiAila SarkeshReza AletahaHamidreza FeiziSeyed Ehsan MousaviSeyed Aria NejadghaderiMark J M SullmanAli-Asghar KolahiSaeid Safiri

Published in: PloS one (2023)

Only a small number of studies have found veliparib to be effective, in terms of improved OS, PFS, and ORR, while the majority of studies found no benefit for veliparib over standard treatment.

Keyphrases

clinical trial
randomized controlled trial
squamous cell carcinoma
combination therapy
locally advanced
rectal cancer
double blind